Coronavirus News and Research

RSS

Placental cell-type productively infected with SARS-CoV-2

A new preprint describes the development of a new platform for evaluating the risk of SARS-CoV-2 infection in placental tissue.

2 Nov 2021

SARS-CoV-2 variants neutralized by camel nanobodies

Researchers from the US recently isolated two VHH nanobodies - 7A3 and 8A2 - from dromedary camels (Camelus dromedaries) using phage display. These nanobodies were found to have a high affinity for the spike RBD and broad neutralization abilities against SARS-CoV-2 and its variants.

2 Nov 2021

Scientists identify compound that shows potential in easing the symptoms of coronavirus infections

By studying a disease caused by a close cousin of the virus behind COVID-19, a team of scientists has identified a compound that shows potential in easing the symptoms of coronavirus infections.

1 Nov 2021

Transmission of COVID-19 from pet parent to pet documented for first time in the U.S.

For the first time in the U.S., the transmission of COVID-19 from pet parent to pet is documented genetically as part of a study by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.

1 Nov 2021

Curious case of SARS-CoV-2 Delta variant in a dog

In a recent study, researchers document the detection and sequencing of an AY.3 virus from a 12-year-old Collie living with a SARS-CoV-2-infected owner.

1 Nov 2021

New Australian study identifies key barriers to COVID-19 testing and vaccination

A new study aimed to bridge the gap in a culturally and linguistically diverse population concerning COVID-19 testing intentions and vaccine willingness.

1 Nov 2021

Evidence antibodies targeting HCoV-OC43 are robustly boosted in response to SARS-CoV-2 but not vaccination

The magnitude of cross-reactive antibodies correlated well with responses to the SARS-CoV-2 spike protein and the S2 subdomain.

1 Nov 2021

Do weather and climate determine where COVID-19 occurs?

A new study provides information on the associations between weather parameters and seasonal coronavirus cases.

1 Nov 2021

Lehigh’s undergraduate students receive NIH Award for new sickle cell diagnostic device

Their tickets were booked. Their schedules were set. The students were finally going to test their product on real people. But in July, Sierra Leone's COVID-19 level spiked almost overnight, and Lehigh's Sickle Cell Anemia Diagnostic Device team lost yet another opportunity to conduct fieldwork.

1 Nov 2021

SARS-CoV-2 antibodies persisting for nearly a year, including to delta: NZ study

A cohort study found that antibodies to the SARS-CoV-2 spike protein and neutralizing antibodies remain relatively stable 8-11 months post-infection.

1 Nov 2021

Investigation of Budesonide's mechanism of action against SARS-CoV-2

Researchers look to gain an understanding of the mechanism of action of budesonide in improving the prognosis of patients with SARS-CoV-2 infection.

1 Nov 2021

Potential link between SARS-CoV-2 infection and secondary occurrence of anti-NMDAR encephalitis

Scientists explore the link between SARS-CoV-2 infection and anti-NMDAR encephalitis.

1 Nov 2021

Can COVID-19 spread through water while swimming?

Scientists explore the evidence on COVID-19 transmission associated with swimming-related activities and the effect of recommended strategies to restrict it.

1 Nov 2021

Curcumin, a bioactive component of turmeric, effectively neutralizes SARS-CoV-2 in vitro

The researchers investigated the neutralizing activity of turmeric root extract, curcumin-containing capsules, and pure curcumin against SARS-CoV-2.

1 Nov 2021

SARS-CoV-2 introduction events in Québec, Canada

Researchers from McGill University have been investigating the number of introduction events in Quebec.

1 Nov 2021

Identification of novel nanobodies to specifically target SARS-CoV-2 replication protein

Researchers have recently identified two nanobodies that show specific binding against a SARS-CoV-2 replication protein.

1 Nov 2021

BNT162b2 mRNA COVID-19 vaccine effectiveness amongst Italian healthcare workers

A new study has been published in Vaccines that evaluated the effectiveness of Cominarty against documented SARS-CoV-2 infection and symptomatic diseases in the medium to long term.

1 Nov 2021

Structural and molecular contributions to understanding antibody recognition of pathogenic viruses

A new review discusses how molecular and structural biology have contributed to our understanding of antibody recognition of HIV-1, SARS-CoV-2, and Zika.

1 Nov 2021

Study finds inhaled microspheres reduce SARS-CoV-2 infective effectiveness

A new study develops an inhaled microfluidic microsphere with a genetically engineered membrane from the ACE2 receptor-overexpressing cells and macrophages.

1 Nov 2021

Factors predicting cognitive symptoms in long COVID

The researchers focused on finding risk factors for long-term symptom occurrence and severity, with special attention to cognitive impairment.

1 Nov 2021

Coronavirus News and Research

Placental cell-type productively infected with SARS-CoV-2

SARS-CoV-2 variants neutralized by camel nanobodies

Scientists identify compound that shows potential in easing the symptoms of coronavirus infections

Transmission of COVID-19 from pet parent to pet documented for first time in the U.S.

Curious case of SARS-CoV-2 Delta variant in a dog

New Australian study identifies key barriers to COVID-19 testing and vaccination

Evidence antibodies targeting HCoV-OC43 are robustly boosted in response to SARS-CoV-2 but not vaccination

Do weather and climate determine where COVID-19 occurs?

Lehigh’s undergraduate students receive NIH Award for new sickle cell diagnostic device

SARS-CoV-2 antibodies persisting for nearly a year, including to delta: NZ study

Investigation of Budesonide's mechanism of action against SARS-CoV-2

Potential link between SARS-CoV-2 infection and secondary occurrence of anti-NMDAR encephalitis

Can COVID-19 spread through water while swimming?

Curcumin, a bioactive component of turmeric, effectively neutralizes SARS-CoV-2 in vitro

SARS-CoV-2 introduction events in Québec, Canada

Identification of novel nanobodies to specifically target SARS-CoV-2 replication protein

BNT162b2 mRNA COVID-19 vaccine effectiveness amongst Italian healthcare workers

Structural and molecular contributions to understanding antibody recognition of pathogenic viruses

Study finds inhaled microspheres reduce SARS-CoV-2 infective effectiveness

Factors predicting cognitive symptoms in long COVID

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News